Come up with a name for your new list and we'll add to it:
RetroVirox raised a round of funding on March 12, 2015. Investors include
National Institutes of Health.
RetroVirox is a privately-held biotechnology company dedicated to discovering new treatments for patients with infectious diseases. The company offers its discovery platforms and antiviral services to…